上海沪震实业有限公司
扫一扫,手机逛起来
主营:ELISA试剂盒,人ELISA试剂盒,小鼠ELISA试剂盒,大鼠ELISA试剂盒,重组蛋白,金标试剂盒,**组化试剂盒,标准品,单克隆抗体,多克隆抗体,生化试剂,生物培养基,原代细胞,细胞株,实验室耗材,动物血清等产品
021-60345367
您现在的位置:
企业信息
9
  • 注册时间:2015-11-06
  • 联系人:游艳
  • 电话:021-60345367
  • 联系时,请说明仪表网看到的
  • Email:shhzsw01@163.com
在线询价
产品详情

HCC1395细胞

  • 如果您对该产品感兴趣的话,可以
  • 产品名称:HCC1395细胞
  • 产品型号:HCC1395
  • 产品展商:HZbscience
  • 产品文档:无相关文档
  • 发布时间:2018-08-24
  • 在线询价
简单介绍
HCC1395细胞应如何避免细胞污染,细胞污染的种类可分成**、酵母菌、霉菌、病毒和霉浆菌。主要的污染原因为无菌操作技术不当、操作室环境不佳、污染之血清和污染之细胞等。严格之无菌操作技术、清洁的环境、与品质良好之细胞来源和培养基配制是减低污染之*好方法。HCC1395细胞何时须更换培养基?视细胞生长密度而定,或遵照细胞株基本数据上之更换时间,按时更换培养基即可。
产品描述

HCC1395细胞

器官来源: **

细胞形态: 上皮样

生长状态: 贴壁生长

ATCC Number: CRL-2324™

相关**: 导管癌

运输方式: 冻存运输

是否是肿瘤细胞: 1

物种来源: 人

组织来源: duct

年限: TNM stage I, grade 3

数量: 大量

HCC1395细胞Designations: HCC1395

Depositors: AF Gazdar, AK Virmani

Biosafety Level: 1

Shipped: frozen

Medium & Serum: See Propagation

Growth Properties: adherent

Organism: Homo sapiens

Morphology: epithelial


Source: Organ: mammary gland; breast

Tissue: duct

Tumor Stage: TNM stage I, grade 3

Disease: primary ductal carcinoma

Cellular Products: Epithelial glycoprotein 2 (EGP2)

cytokeratin 19

Permits/Forms: HCC1395细胞In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.

Restrictions: The line is available with the following restrictions: 1. This cell line was deposited at the ATCC by Dr. Adi F. Gazdar and is provided for research purposes only. Neither the cell line nor products derived from it may be sold or used for commercial purposes. Nor can the cells be distributed to third parties for purposes of sale, or producing for sale, cells or their products. The cells are provided as service to the research community. They are provided without warranty of merchantability or fitness for a particular purpose or any other warranty, expressed or implied. 2. Any proposed commercial use of the these cells, or their products must first be negotiated with the University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Blvd., Dallas, Texas 75235. Telephone (214) 648-1888, Email TechnologyDevelopment@UTSouthwestern.edu, or Fax: (214) 951-0935.

Isolation: Isolation date: December 14, 1994

Applications: The cells are poorly differentiated and vacuolated.

The cells are negative for expression of Her2-neu but positive for expression of p53.

HCC1395 is positive for the epithelial cell specific marker Epithelial Glycoprotein 2 (EGP2) and for cytokeratin 19.

The cells are negative for expression of estrogen receptors (ER -) according to depositor and negative for expression of progesterone receptors (PR -).

Receptors: estrogen receptor, negative according to depositor

progesterone receptor, negative

Oncogene: her2/neu -, p53 +

DNA Profile (STR): HCC1395细胞Amelogenin: X

CSF1PO: 11

D13S317: 9

D16S539: 11

D5S818: 11

D7S820: 10,12

THO1: 9.3

TPOX: 11

vWA: 15

Cytogenetic Analysis: polyploid

Age: 43 years *****

Gender: female

Ethnicity: Caucasian, White

Comments: This cell line was initiated on 12/14/94 from a patient with a family history of cancer (patient's mother had breast cancer).

The cell line took 14 months to establish.

The tumor was classified as TNM stage I, grade 3, invasive ductal carcinoma with 0 out of 34 lymph node metastasis.

The cells are poorly differentiated and vacuolated.

The cells are negative for expression of Her2-neu but positive for expression of p53.

HCC1395 is positive for the epithelial cell specific marker Epithelial Glycoprotein 2 (EGP2) and for cytokeratin 19.

The cells are negative for expression of estrogen receptors (ER -) according to depositor and negative for expression of progesterone receptors (PR -).

An EBV transformed lymphoblastoid cell line (HCC1395BL) from the same patient is available as ATCC CRL-2325.

Propagation: HCC1395细胞ATCC complete growth medium: The base medium for this cell line is ATCC-formulated RPMI-1640 Medium, Catalog No. 30-2001. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 10%.

Temperature: 37.0°C

Atmosphere: air, 95%; carbon dioxide (CO2), 5%

Subculturing: Protocol: Remove medium, and rinse with 0.25% trypsin, 0.53 mM EDTA solution. Remove the solution and add an additional 1 to 2 ml of trypsin-EDTA solution. Allow the flask to sit at room temperature (or at 37C) until the cells detach. Add fresh culture medium, aspirate and dispense into new culture flasks.

Subcultivation Ratio: A subcultivation ratio of 1:2 is recommended

Medium Renewal: Every 2 to 3 days

Preservation: Freeze medium: Complete growth medium 95%; DMSO, 5%

Storage temperature: liquid nitrogen vapor phase

Related Products: Recommended medium (without the additional supplements or serum described under ATCC Medium):ATCC 30-2001

recommended serum:ATCC 30-2020

purified DNA:ATCC CRL-2324D

normal (or near-normal) cell line established from the same patient:ATCC CRL-2325

purified RNA:ATCC CRL-2324R

cell pellet:ATCC CRL-2324P

References: 38266: Gazdar AF, et al. HCC1395细胞Characterization of paired tumor and non-tumor cell lines established from patients with breast cancer. Int. J. Cancer 78: 766-774, 1998. PubMed: 9833771

关于我们| 易展动态| 易展荣誉| 易展服务| 易家文化| 英才集结号| 社会责任| 联系我们

备案号:粤ICP备11010883号| 公安机关备案号:44040202000312| 版权问题及信息删除: 0756-2183610  QQ: 服务QQ

Copyright?2004-2017  珠海市金信桥网络科技有限公司 版权所有

行业网站百强奖牌 搜索营销*有价值奖 中小企业电子商务**服务商
以上信息由企业自行提供,信息内容的真实性、准确性和合法性由相关企业负责,易展仪表展览网对此不承担任何保证责任。

沪公网安备 31011702004356号